Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 101 ~ 120 of 25905, Page 6 of 1296
101. Statement from FDA Commissioner Scott Gottlieb, M.D., and Susan Mayne, Ph.D., director of the Center for Food Safety and Applied Nutrition, on tests confirming a 2017 finding of asbestos contamination in certain cosmetic products and new steps that FDA is pursuing to improve cosmetics safety
102. FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic
103. Are You Getting Enough Vitamin D?
Our bodies need vitamin D for healthy bones. And some studies suggest it may be linked with lower colorectal cancer risk. Find out how much vitamin D you need and how to get it safely.
03/05/2019 American Cancer Society
104. Merck Begins Tender Offer to Acquire Immune Design
03/05/2019 MERCK
105. Abbott''s Latest Diagnostics Technology, Alinity, Selected by Regional Medical Laboratory, Inc. to Deliver Benefits to Hospitals and Patients
Regional Medical Laboratory, Inc., which is part of the Ascension network, partners with Abbott, the global health leader, to advance lab capabilities and help improve health outcomes
03/05/2019 Abbott
106. Merck Prices $5.0 Billion Debt Offering
03/05/2019 MERCK
107. A Healthy Diet is No Fad
If that new diet sounds too good to be true, it probably is. Instead of joining the latest weight-loss craze, make smart lifestyle changes that add up to long-term healthy eating and exercise habits.
03/05/2019 American Cancer Society
108. RSNA Offers First U.S. Spotlight Course on Artificial Intelligence
OAK BROOK, Ill. (March 4, 2019)?The Radiological Society of North America (RSNA) continues its commitment to artificial intelligence (AI) education with two new regional courses this spring, including the first RSNA Spotlight course to be held in the U.S.
03/04/2019 Radiological Society of North America
109. European Medicines Agency Adopts Positive Opinion for Merck’s KEYTRUDA® (pembrolizumab) for Six-Week Dosing Schedule Across All Current Monotherapy Indications
In the EU, KEYTRUDA as monotherapy is currently approved for eight indications across five tumor types
03/04/2019 MERCK
110. Statement from FDA Commissioner Scott Gottlieb, M.D., on forceful new actions focused on retailers, manufacturers to combat youth access to e-cigarettes as part of FDA’s Youth Tobacco Prevention Plan
111. Medtronic Announces the Upsizing of its Maximum Tender Offers for Certain Outstanding Debt Securities Issued by Medtronic, Inc. and Covidien International Finance S.A.
03/04/2019 Medtronic
112. Medtronic Announces Pricing of €7.0 Billion of Senior Notes
03/04/2019 Medtronic
113. Spring Break Travel Advisory: Pack Backup Contact Lens Supplies to Avoid Infections
American Academy of Ophthalmology and the American Academy of Optometry are joining the Centers for Disease Control and Prevention to offer spring break safety tips so travelers spend their time on the beach, not in the emergency room.
03/04/2019 American Academy of Ophthalmology
114. Cervical Precancers Drop Since Introduction of HPV Vaccine
A study using data from the Centers for Disease Control and Prevention (CDC) provides evidence that the human papillomavirus (HPV) vaccine is effectively reducing the numbers of cervical precancer ? lesions that can become cervical cancer.
03/01/2019 American Cancer Society
115. FDA provides update on its ongoing investigation into ARB drug products; reports on finding of a new nitrosamine impurity in certain lots of losartan and product recall
The U.S. Food and Drug Administration is updating the public on the agency’s ongoing investigation surrounding the recent voluntary recalls of multiple generic angiotensin II receptor blocker (ARB) drug products used to treat high blood pressure and heart failure.
116. Medtronic Statement Regarding IN.PACT Paclitaxel Safety Analysis Correction Letter in The Journal of the American College of Cardiology
03/01/2019 Medtronic
117. LYNPARZA® (olaparib) Receives Positive EU CHMP Opinion For Use in Germline BRCA-Mutated HER2-Negative Advanced Breast Cancer
03/01/2019 MERCK
118. Medtronic EVP & CFO Karen L. Parkhill to Speak at Barclays Global Healthcare Conference
03/01/2019 Medtronic
119. Medtronic EVP & MITG President Bob White to Speak at Cowen Healthcare Conference
03/01/2019 Medtronic
120. FDA warns CanaRx for selling unapproved, misbranded and unsafe imported drugs to unsuspecting Americans
CanaRx claims its drugs are safe and effective medicines; instead, its violations endanger consumers
1 2 3 4 5 6 7 8 9 10
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱